American Century Companies
SGMO

American Century Companies’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

American Century Companies’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-105,337
Closed -$107K – 2947
2024
Q4 		$107K Buy
+105,337
New +$193K ﹤0.01% 2831
2023
Q2 		– Sell
-44,546
Closed -$75.7K – 2835
2023
Q1 		$75.7K Buy
44,546
+4,307
+11% +$12.3K ﹤0.01% 2580
2022
Q4 		$126K Buy
40,239
+4,333
+12% +$16.8K ﹤0.01% 2421
2022
Q3 		$176K Sell
35,906
-89
-0.2% -$457 ﹤0.01% 2249
2022
Q2 		$149K Buy
35,995
+870
+2% +$3.76K ﹤0.01% 2187
2022
Q1 		$204K Buy
35,125
+282
+0.8% +$1.68K ﹤0.01% 2176
2021
Q4 		$261K Sell
34,843
-58,502
-63% -$508K ﹤0.01% 2129
2021
Q3 		$841K Sell
93,345
-37,358
-29% -$369K ﹤0.01% 1672
2021
Q2 		$1.56M Sell
130,703
-32,262
-20% -$365K ﹤0.01% 1368
2021
Q1 		$2.04M Buy
162,965
+125,240
+332% +$1.69M ﹤0.01% 1159
2020
Q4 		$589K Buy
37,725
+16,868
+81% +$198K ﹤0.01% 1488
2020
Q3 		$197K Buy
+20,857
New +$226K ﹤0.01% 1687
2018
Q4 		– Sell
-181,009
Closed -$3.07M – 1332
2018
Q3 		$3.07M Sell
181,009
-87,189
-33% -$1.33M ﹤0.01% 953
2018
Q2 		$3.81M Sell
268,198
-58,077
-18% -$965K ﹤0.01% 901
2018
Q1 		$6.2M Sell
326,275
-142,824
-30% -$3.05M 0.01% 780
2017
Q4 		$7.69M Buy
469,099
+126,121
+37% +$1.88M 0.01% 735
2017
Q3 		$5.14M Buy
+342,978
New +$3.79M 0.01% 847
2015
Q3 		– Sell
-80,756
Closed -$896K – 1416
2015
Q2 		$896K Sell
80,756
-154,055
-66% -$1.99M ﹤0.01% 1161
2015
Q1 		$3.68M Buy
234,811
+79,639
+51% +$1.23M ﹤0.01% 930
2014
Q4 		$2.36M Sell
155,172
-23,473
-13% -$285K ﹤0.01% 1049
2014
Q3 		$1.93M Buy
178,645
+61,680
+53% +$806K ﹤0.01% 1077
2014
Q2 		$1.79M Buy
+116,965
New +$1.68M ﹤0.01% 1120

Other funds holding SGMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

American Century Companies's SGMO Position: Q1 2025 in Review

American Century Companies sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2025, closing a stake of 105,337 shares — an estimated $107K sold.

American Century Companies first reported a position in SGMO in Q2 2014 and held it in 22 quarters. The position peaked at $7.69M in Q4 2017. 122 funds tracked by Wall St. Rank hold SGMO as of Q1 2025.

  • American Century Companies reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2025 after selling out during the quarter.
  • American Century Companies sold 105,337 SANGAMO THERAPEUTICS INC shares in Q1 2025, an estimated $107K.
  • American Century Companies first reported a position in SANGAMO THERAPEUTICS INC in Q2 2014 and held it in 22 quarters.
  • American Century Companies's SANGAMO THERAPEUTICS INC position peaked at $7.69M in Q4 2017.
  • 122 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2025.

Based on American Century Companies's 13F filing for Q1 2025, filed 13 May 2025.